One Wealth Advisors, LLC Biogen Inc. Transaction History

One Wealth Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $11,835 - $13,676	-43 Reduced 5.05%	809 $230,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $215,078 - $261,325	852 New	852 $235,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $181,599 - $233,381	-811 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $74,426 - $97,060	-263 Reduced 24.49%	811 $230,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $48,433 - $77,550	-187 Reduced 14.83%	1,074 $372,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $19,193 - $22,485	79 Added 6.68%	1,261 $353,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $21,972 - $33,073	-93 Reduced 7.29%	1,182 $289,000
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $74,929 - $86,515	283 Added 28.53%	1,275 $362,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $75,270 - $99,682	291 Added 41.51%	992 $265,000
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $188,463 - $239,069	701 New	701 $222,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $1,315 - $1,450	-6 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $1,300 - $2,033	6 New	6 $1,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of One Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on One Wealth Advisors, LLC with notifications on news.